CRISPR Therapeutics AG

CRISPR Therapeutics AG

CRSP

Market Cap$4.91B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
CRISPR Therapeutics AGCRISPR Therapeutics AG-12.7--21%-0.1
$-3.73

Current Fair Value

106.8% downside

Overvalued by 106.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$4.91 Billion
Enterprise Value$4.89 Billion
Dividend Yield$0 (0%)
Earnings per Share$-4.34
Beta1.74
Outstanding Shares85,938,720

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-12.66
PEG-76.05
Price to Sales-
Price to Book Ratio2.62
Enterprise Value to Revenue135.49
Enterprise Value to EBIT-10.21
Enterprise Value to Net Income-13
Total Debt to Enterprise0.05
Debt to Equity0.12

Revenue Sources

No data

Insider Trades

ESG Score

No data

About CRISPR Therapeutics AG

CEO: Samarth Kulkarni